Outcome of T1N0M0 Squamous Cell Carcinoma of the Larynx Treated with Short-course Radiotherapy to a Total Dose of 50 Gy in 16 Fractions: the Birmingham Experience

Radiotherapy to a total dose of 50 Gy in 16 fractions for T1N0M0 squamous cell carcinoma of the larynx offers high locoregional control rates with voice preservation. These results from a hypofractionated radiotherapy schedule are comparable with other longer fractionation schedules and offer potential for optimising resource usage.